Authors
Loading...
Analyses reveal dysregulated proteins and metabolites in proliferative diabetic retinopathy, suggesting novel biomarkers and therapeutic targets.
Cui et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: